ORCHESTRA BIOMED HOLDI

5.5700

25-November-24 15:45:01

15 minutes delayed

Stocks

-0.2000

-3.47%

Today's range

5.4200 - 5.9400

ISIN

N/A

Source

NASDAQ

Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis

08 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes

26 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer

07 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
Orchestra BioMed to Present at the Jefferies Global Healthcare Conference

01 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update

12 May 2023 08:15:18 By Nasdaq GlobeNewswire
Orchestra BioMed to Present at Upcoming Investor Conferences

07 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT™ and Virtue® SAB at CRT 2023

24 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.